Cite
IL-8 is a novel prometastatic chemokine in intrahepatic cholangiocarcinoma that induces CXCR2-PI3K/AKT signaling upon CD97 activation.
MLA
Meng, Ze-Wu, et al. “IL-8 Is a Novel Prometastatic Chemokine in Intrahepatic Cholangiocarcinoma That Induces CXCR2-PI3K/AKT Signaling upon CD97 Activation.” Scientific Reports, vol. 13, no. 1, Oct. 2023, pp. 1–14. EBSCOhost, https://doi.org/10.1038/s41598-023-45496-3.
APA
Meng, Z.-W., Zhang, L., Cai, X.-R., Wang, X., She, F.-F., & Chen, Y.-L. (2023). IL-8 is a novel prometastatic chemokine in intrahepatic cholangiocarcinoma that induces CXCR2-PI3K/AKT signaling upon CD97 activation. Scientific Reports, 13(1), 1–14. https://doi.org/10.1038/s41598-023-45496-3
Chicago
Meng, Ze-Wu, Lei Zhang, Xin-Ran Cai, Xing Wang, Fei-Fei She, and Yan-Ling Chen. 2023. “IL-8 Is a Novel Prometastatic Chemokine in Intrahepatic Cholangiocarcinoma That Induces CXCR2-PI3K/AKT Signaling upon CD97 Activation.” Scientific Reports 13 (1): 1–14. doi:10.1038/s41598-023-45496-3.